Feline CYFRA21-1 antibody and antigen (recombinant protein)

Diagnostic anti-Feline CYFRA21-1 antibodies pairs and antigen for animal health (animal Cat/Feline bronchopulmonary dysplasia) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-FEL-CYFRA21-1-Ag01 Recombinant Feline CYFRA21-1 protein 3090
GMP-FEL-CYFRA21-1-Ab01 Anti-Feline CYFRA21-1 mouse monoclonal antibody (mAb) 1953
GMP-FEL-CYFRA21-1-Ab02 Anti-Feline CYFRA21-1 mouse monoclonal antibody (mAb) 1953
GMP-FEL-CYFRA21-1-Ab03 Anti-Feline CYFRA21-1 human monoclonal antibody (mAb) 1953
GMP-FEL-CYFRA21-1-Ab04 Anti-Feline CYFRA21-1 human monoclonal antibody (mAb) 1953

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Products GMP-FEL-CYFRA21-1-Ag01
Product Name Recombinant Feline CYFRA21-1 protein
Target/Biomarker Feline soluble fragment of cytokeratin-19 (CYFRA21-1)
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Feline soluble fragment of cytokeratin-19 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CYFRA21-1 level test of animal Cat/Feline with bronchopulmonary dysplasia.
Tag His
Products description Recombinant Feline CYFRA21-1 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-FEL-CYFRA21-1-Ab01, GMP-FEL-CYFRA21-1-Ab02
Product Name Anti-Feline CYFRA21-1 mouse monoclonal antibody (mAb)
Target/Biomarker Feline soluble fragment of cytokeratin-19 (CYFRA21-1)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Feline soluble fragment of cytokeratin-19 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies in CYFRA21-1 level test of animal Cat/Feline with bronchopulmonary dysplasia.
Tag mFc
Products description Anti-Feline CYFRA21-1 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-FEL-CYFRA21-1-Ab03, GMP-FEL-CYFRA21-1-Ab04
Product Name Anti-Feline CYFRA21-1 human monoclonal antibody (mAb)
Target/Biomarker Feline soluble fragment of cytokeratin-19 (CYFRA21-1)
Expression platform CHO
Isotypes Human IgG1
Bioactivity validation Recombinant Feline soluble fragment of cytokeratin-19 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies in CYFRA21-1 level test of animal Cat/Feline with bronchopulmonary dysplasia.
Tag hFc
Products description Anti-Feline CYFRA21-1 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CYFRA21-1 antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    CYFRA21-1, also known as Cytokeratin 19 Fragment 21-1, is a noteworthy biomarker within the context of cats (felines). It originates from cytokeratin 19, a structural protein that plays a pivotal role in maintaining the cytoskeletal integrity of epithelial cells. Epithelial cells are a fundamental component of various feline tissues and organs, including the respiratory system. When these cells experience pathological changes, such as injury or malignant transformation, CYFRA21-1 fragments can be released into the bloodstream, making it a valuable indicator of epithelial cell health. At the molecular level, CYFRA21-1 is composed of specific fragments of cytokeratin 19, notably the 21-1 fragment. These soluble protein fragments can be detected through blood tests. In healthy cats, CYFRA21-1 levels are typically low. However, when there is damage or malignancy in epithelial tissues, such as the lungs, the levels of CYFRA21-1 can significantly increase. This makes CYFRA21-1 a crucial biomarker for assessing the health of the respiratory and epithelial systems in felines.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment